sutures newsletter

PRODUCED BY AND FOR MEMBERS OF THE DEPARTMENT OF SURGERY February 2016 | Archived Issues

Mark Your Calendar


Surgery Grand Rounds

Click the "read more" to see information about upcoming Surgery Grand Rounds.


Grand Rounds

Click here to view a schedule of all upcoming grand rounds.


Education Schedule

Click the PDF links below to see the Department of Surgery's education schedule.

Education Schedule - February 2016 (PDF)  


Surgery Scheduling

Click the "read more" for hours and contact information for surgery scheduling.

Share Your News

Know an interesting colleague we should profile? A story we should tell? Submit your ideas, meetings and events for consideration.

Click here to submit your news to Sutures

Cedars-Sinai Hosts CIRM-Israel Pact Signing

CIRM_480px

Jonathan Thomas, PhD, JD, chair of the Governing Board of the California Institute for Regenerative Medicine, (left) and Ofir Akunis, Israel's Minister of Science, Technology and Space, signed a cooperation agreement at Cedars-Sinai.

Cedars-Sinai on Feb. 8 hosted the signing of a major agreement to advance U.S-Israeli collaboration on stem cell research. The pact, between the California Institute for Regenerative Medicine (CIRM) and Israel's Ministry of Science, Technology and Space, provides a new framework to foster global partnerships and joint funding opportunities in regenerative medicine.

Shlomo Melmed

Shlomo Melmed, MD, executive vice president of Academic Affairs and dean of the medical faculty, delivered welcoming remarks.

The CIRM, created by a 2004 statewide voter initiative, has provided millions of dollars to Cedars-Sinai and other institutions to develop new therapies for deadly diseases and disorders using stem-cell technologies.

"This agreement will deepen the partnership between Israel and California, bringing together our most talented scientists to push the boundaries of stem cell research," said Ofir Akunis, Israel’s Minister of Science, Technology and Space, who signed the agreement for Israel. Jonathan Thomas, PhD, JD, chair of the CIRM Governing Board, signed on behalf of his agency. Key Cedars-Sinai leaders witnessed the ceremony.

In welcoming remarks, Shlomo Melmed, MD, executive vice president of Academic Affairs and dean of the medical faculty, said, "Cedars-Sinai has made a significant commitment to stem cell research, with very productive results." He said the experimental technology has proven effective in several areas of promise, including regenerating tissue in bone fractures and reversing heart attack damage.

Referring to the new agreement, Melmed, a CIRM board member, said, "This partnership will prove fruitful and be of great benefit to all of California stem cell science, as well as to our patients here at Cedars-Sinai."